Pippa Mann will compete in the Indianapolis 500 Mile Race on May 24 in a Dale Coyne Racing Honda.
For the second consecutive year, Mann will be driving a pink car as she races in support of Susan G. Komen, the world’s largest breast cancer organization.
“It was an honor last year to be able to partner with Susan G. Komen,” said Mann, 31, of England. “By bringing Komen’s iconic images and colors to the Indy 500, we were able to promote its cause, while raising funds and awareness for Komen’s mission.”
The 99th Running of the Indianapolis 500 will be Mann’s third with Dale Coyne Racing and the fourth time she has competed on the 2.5-mile oval in the Verizon IndyCar Series.
“The last time I strapped into a race car may have been last May, but I feel very fortunate to have had such strong support from the Dale Coyne Racing team and from team owner Dale Coyne over the past 12 months. We are all thrilled to bring this pink program back for a second year running.”
Mann qualified a personal-best 22nd in the 2014 Indianapolis 500. After a mechanical issue forced an extra pit stop, she finished 24th position.
“There is nothing that makes our team prouder than to represent Susan G. Komen and all of the hard work that goes into the organization’s efforts both in the U.S. and around the world,” Coyne said. “Pippa is extremely dedicated to her efforts as a driver at Indy and we look forward to our continued success with this partnership.”
Mann will participate in the May 3 Promoter Test on the oval with the new speedway aerodynamic bodywork package.
In an effort to increase awareness and donations from last year’s fundraising, 2015 will bring supporters an interactive campaign that will allow them to get involved. This new campaign will bring fans closer to the action and assist Komen as it works toward its mission of finding the cures.
“Pippa’s passion for our cause inspires us all,” said Komen president and CEO Judy Salerno. “Whether on the track or out in the community, her commitment to raising awareness and funds brings us one step closer to a world without breast cancer.”